| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911049 | Lung Cancer | 2013 | 4 Pages |
Abstract
In this retrospective analysis of population based registry patients, SCS did not provide additional prognostic information in patients with lung cancer. ECOG performance status may be a substitute for the effect of comorbidity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David Ball, Vicky Thursfield, Louis Irving, Paul Mitchell, Gary Richardson, Yvonne Torn-Broers, Gavin Wright, Graham Giles,